Study to Create Potential Cell-Based Therapies to Treat Human Disease and Disability

Trial ID or NCT#

NCT00553826

Status

not recruiting iconNOT RECRUITING

Purpose

This is a research study in which your cells will be used for somatic cell nuclear transfer (SCNT), and/or genetic reprogramming research which may result in the production of stem cell lines. This study does not provide treatment.

Official Title

Derivation of Primary Donor Cell Lines for Human Cell Reprogramming

Eligibility Criteria

Ages Eligible for Study: 1 Year to 75 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes
Inclusion Criteria:
  1. 1. Donors with a degenerative disease phenotype or genetic disorders such as Type I Diabetes, heart disease, or infertility (azoospermia and premature ovarian failure)
Exclusion Criteria:
  1. 1. Unable to read or understand English. 2. Unable to provide skin biopsy sample due to skin condition in the underarm area.
View All Criteria
Show Less

Investigator(s)

Marius Wernig

Contact us to find out if this trial is right for you.

Contact

Tasha Kalista
6507259977

View on ClinicalTrials.gov